SHH and neoplasm: C-terminal anti-Shh antibody 1C11-2G4 inhibited tumor growth in mouse xenografts of lung cancer in vivo, suggesting that our novel therpeutic may successfully target Shh and cell-mediated hedgehog signalling via C-term epitope binding.